← Open Payments lookup

CHANDA COPELAND: Open Payments

NPI 1477820769 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,208 in 102 payments from 19 companies in 2025. Trend: 2023 $1,309 · 2024 $1,610 · 2025 $2,208

Food & beverage: $2,208
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation19$452
UCB, Inc.18$225
Organon LLC10$210
Galderma Laboratories, L.P.4$210
Amgen Inc.4$203
ABBVIE INC.13$153
PFIZER INC.5$116
Janssen Biotech, Inc.3$103
GENZYME CORPORATION4$102
Medimetriks Pharmaceuticals, Inc.5$98

Products named: Bimzelx, NEMLUVIO, OTEZLA, SKYRIZI, COSENTYX, VTAMA, DUPIXENT, CIBINQO.

Industry payments across DC — which companies pay providers there.